AAIC 2026 | What are the biological mechanisms underlying the higher prevalence of AD in women?

Amber Watts, MD, University of Kansas, Lawrence, KS, comments on the biological mechanisms underlying the higher prevalence of Alzheimer’s disease (AD) in women. Prof. Watts discusses the role of estrogen and menopause, as well as the potential protective effects of hormone-based birth control and menopausal hormone therapy. This interview took place at the 2026 Alzheimer’s Association International Conference (AAIC) in London, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.